Xybion Corporation announced that the animal health company has chosen Xybion's Pristima® Suite to automate and manage its preclinical operations globally. Xybion's Pristima Suite isa software application built to help life science, animal health and drug development companies manage highly regulated and complex preclinical processes at a global level.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.9 CAD | +2.27% | -.--% | +81.82% |
1st Jan change | Capi. | |
---|---|---|
+32.09% | 384B | |
+31.39% | 232B | |
+4.19% | 151B | |
+27.45% | 64.82B | |
+37.70% | 39.61B | |
+151.73% | 28.2B | |
-17.26% | 24.48B | |
+24.47% | 22.19B | |
+45.78% | 14.78B |
- Stock Market
- Equities
- XYBN Stock
- News XYBN DIGI
- Global Animal Products Company Selects Xybion Corporation's Pristima Suite to Automate and Manage Global Preclinical